Back to results
US 9,408,928 B2Granted
Compositions for targeted imaging and therapy
AssigneeRadioMedix Inc.
InventorsAli Azhdarinia, Ebrahim S. Delpassand, Izabela Tworowska, Jennifer Sims-Mourtada
Life of this patent
Estimating the term…
Abstract
The present invention relates to the field of radiochemistry, nuclear imaging, radionuclide therapy and chemical synthesis. More particularly, it concerns a strategy for radiolabeling target ligands. It further concerns methods of using those radiolabeled ligands for imaging, radionuclide therapy and tissue-specific disease imaging.
Claims16
A composition comprising a DO2S derivative having a structure:
- and
- wherein the composition is for diagnosing or treating cancer, wherein the ligand is a carbohydrate.
A composition comprising a DO2S derivative having a structure:
- and
- wherein the composition is for treating cancer, wherein the ligand is a carbohydrate.
Dependencies are inferred from the claim text.